Hostname: page-component-7b7567c8c-wxvwp Total loading time: 0 Render date: 2026-11-17T03:45:28.009Z Has data issue: false hasContentIssue false

Pentamidine: A Review

Published online by Cambridge University Press:  21 March 2023

Brian Wispelwey*
Affiliation:
Departments of Internal Medicine and Pathology, the Divisions of Infectious Diseases and Geographic Medicine, the University of Virginia, Charlottesville, Virginia
Richard D. Pearson
Affiliation:
Departments of Internal Medicine and Pathology, the Divisions of Infectious Diseases and Geographic Medicine, the University of Virginia, Charlottesville, Virginia
*
University of Virginia, Division of Infectious Diseases, Box 397, Charlottesville, VA 22908

Extract

With the advent of the acquired immunodeficiency syndrome (AIDS), the therapeutic importance of pentamidine isethionate has increased greatly. This review summarizes the pharmacology, clinical experience in the treatment of Pneumocystis carinii pneumonia, and toxicity of pentamidine. Data are conflicting as to whether pentamidine is more or less effective than trimethoprim-sulfamethoxazole (TMP-SX) for the treatment of P carinii pneumonia in individuals with AIDS, but due to its toxicity and expense, it is considered as second-line therapy for P carinii pneumonia by many authorities. Hypoglycemia has been encountered in up to 27%, and nephrotoxicity in 25%, of treatment courses with pentamidine. In an attempt to circumvent the toxicities associated with parenteral administration, aerosolized delivery has been evaluated for both therapy and prevention of P carinii pneumonia. Aerosolized pentamidine, on the basis of early clinical results, convenience, and low toxicity, is being used extensively to prevent P carinii pneumonia in individuals at high risk. Relapses occur, however, and pneumothorax may be more common in those using this form of prophylaxis. Aerosolized pentamidine should not be used as sole therapy for acute P carinii pneumonia.

Information

Type
Clinical Pharmacology of Antibiotics
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1991 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable